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SUMMARY
Although poly-ADP-ribosylation (PARylation) of DNA
repair factors had been well documented, its role in
the repair of DNA double-strand breaks (DSBs) is
poorly understood. NR4A nuclear orphan receptors
were previously linked to DSB repair; however, their
function in the process remains elusive. Classically,
NR4As function as transcription factors using a
specialized tandem zinc-finger DNA-binding domain
(DBD) for target gene induction. Here, we show
that NR4A DBD is bi-functional and can bind poly-
ADP-ribose (PAR) through a pocket localized in
the second zinc finger. Separation-of-function mu-
tants demonstrate that NR4A PAR binding, while
dispensable for transcriptional activity, facilitates
repair of radiation-induced DNA double-strand
breaks in G1. Moreover, we define DNA-PKcs pro-
tein as a prominent target of ionizing radiation-
induced PARylation. Mechanistically, NR4As func-
tion by directly targeting poly-ADP-ribosylated
DNA-PKcs to facilitate its autophosphorylation-pro-
moting DNA-PK kinase assembly at DNA lesions.
Selective targeting of the PAR-binding pocket of
NR4A presents an opportunity for cancer therapy.
INTRODUCTION
Nuclear DNA is under a constant threat of damage by reactive
oxygen species, aberrant activity of enzymes and/or exogenous
radiation. Therefore, efficient DNA repair is essential for survival
of all organisms (Jackson and Bartek, 2009). Although double-
strand breaks (DSBs) can be repaired by several pathways,
classical non-homologous end joining (c-NHEJ) is responsible
for the bulk of DSB repair (Waters et al., 2014). NHEJ is initiated
by sequence-independent binding of Ku70/Ku80 dimers to
exposed DNA ends at DSBs. DNA-bound Ku rapidly recruits
DNA-PKcs kinase, resulting in its activation andDNA-PKcs auto-
phosphorylation. Some DSBs undergo processing by Artemis
nuclease before ligation of DNA ends catalyzed by the XRCC4/
LigaseIV complex (Chiruvella et al., 2013). Posttranslational pro-
tein modifications have important regulatory function in DSB
repair (Polo and Jackson, 2011). For example, protein poly-
ADP-ribosylation (PARylation) catalyzed by poly-ADP-ribose
polymerases (PARPs) (Crawford et al., 2018; Luo and Kraus,
2012) has been implicated in c-NHEJ (Luijsterburg et al., 2016)
and can stabilize protein-protein interactions because of func-
tion of specialized poly-ADP-ribose (PAR)-binding domains
(Ahel et al., 2008). The NR4A family of nuclear orphan receptors
consists of three members in mammals (NR4A1–NR4A3) and
one member in Drosophila (DHR38). NR4As are sequence-spe-
cific DNA-binding transcription factors that regulate essential
cellular processes such as cell growth, metabolism, and differ-
entiation (Safe et al., 2016). NR4As possess a conserved DNA-
binding domain (DBD) composed of two zinc fingers (Zn1 and
Zn2). Typically, the Zn1 contacts DNA (Meinke and Sigler,
1999), while Zn2 is not involved in direct DNA binding. A direct
role for NR4As has been discovered in DNA DSB repair, but
the mechanism remains elusive (Jagirdar et al., 2013; Malewicz
et al., 2011; Ramirez-Herrick et al., 2011; Smith et al., 2008;
Yin et al., 2017). Here we show that NR4As’ DBD is functionally
unique, because it is able to bind both DNA and PAR. PAR
binding occurs through the Zn2 region and targets poly-ADP-ri-
bosylated DNA-PKcs to facilitate activity of the DNA-PK repair
complex during c-NHEJ. Altogether, we define a function of
NR4As in DSB repair and propose a way for pharmacological
targeting of NR4A in cancer therapy.
RESULTS
Conserved Zn2 of NR4A2 Encodes a PAR-Binding
Domain
Given that NR4A recruitment to DNA damage sites depends on
PAR (Figure 1A) (Jagirdar et al., 2013; Malewicz et al., 2011),
we asked whether NR4As could bind PAR directly. Recombinant
NR4A2 protein strongly bound PAR (Figure 1B; Figures S1A–
S1D). The ability to bind PAR resides in the second zinc finger
(Zn2) of the NR4A2 DBD (Figures 1B and 1C). Although the
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Figure 1. NR4A Nuclear Receptors Encode a Potent PAR-Binding Domain in Zn2 of Their DNA-Binding Domain
(A) Laser microirradiation with transiently transfected mCherry-NR4A2 fusion proteins in cells pre-treated with DMSO vehicle or PARP inhibitor (PARPi). Arrow
shows the irradiated position in the nucleus. Images have been taken at indicated time points after laser irradiation (s, seconds). Scale bar, 10 mm.
(B) Radioactive poly-ADP-ribose (PAR) dot blot binding assays with recombinant proteins produced in E. coli. Ponceau S stain is used as protein loading control
(Ponceau).
(C) Schematic representation of the NR4A DNA-binding domain. Red box denotes the PAR-binding domain. Amino acids in red indicate residues involved in PAR
binding; underlined residues are involved in DNA binding. Circled is the key residue involved in PAR binding. Middle panel shows a schematic representation of
the NR4A protein structure. Vertical dashed lines show the position of the PAR-binding domain within the NR4A. F-L, full-length; NTD, N-terminal domain; DNA-
binding (DBD), DNA-binding domain; LBD, ligand-binding domain; Zn1, zinc finger 1; Zn2, zinc finger 2; CTE, C-terminal extension; AF, transactivation domain.
(legend continued on next page)
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isolated Zn2 region bound PARweakly (Figure 1B,middle panel),
addition of either Zn1 or C-terminal extension (CTE) restored
PAR binding, suggesting that either Zn2 alone does not fold
properly or Zn1 and CTE might contribute allosterically to Zn2
function (Figure 1B, lower panel). PAR-binding ability extends
to all NR4A family members, including the Drosophila NR4A
homolog DHR38 (Figure 1D). PAR and NR4A interaction is
physiologically relevant, because it is comparable to that of the
LigaseIV BRCT domain (Figure 1E), which binds PAR with nano-
molar affinity (Li et al., 2013).
DNA Binding and PAR Binding by NR4A2 Can Be
Separated Biochemically
In the crystal structure of NR4A1 bound to DNA oligonucleotide
(Meinke and Sigler, 1999), the Zn2 region is protruding away
from DNA and does not contact DNA (Figure 2A). We thus
assumed that separation of function between DNA binding
and PAR binding would be possible. PAR recognition typically
occurs via basic and aromatic amino acid residues (Ahel
et al., 2008). We have generated various point mutants in full-
length NR4A2 and assayed for PAR binding (Figure 2B;
Figure S2A). Several mutants with reduced affinity for PAR
were found. Combining these mutations in a quadruple mutant
(KRRY) showed almost complete absence of PAR binding.
None of thesemutants showed any effect on sequence-specific
DNA binding (Figure 2C). In contrast, arginine residue 319
(R319), conserved across the whole NR family (Figure S1E),
contacts DNA (Meinke and Sigler, 1999), and R319A mutation
abolished DNA binding (Figure 2C; Figure S2B) without
affecting PAR binding (Figure 2B). All mutants (except R319A)
prominently induced NR4A-specific reporter genes (Figure 2D)
and showed normal nuclear localization (Figure 2E). To exclude
a possibility that our synthetic reporter experiments failed
to account for promoter- or enhancer-specific effects we
identified the cellular gene C8ORF4/TC-1 inducible by wild-
type (WT) NR4A2 (but not R319A mutant) (Figure 2F; Table
S1). NR4A2 K303A also induced expression of C8ORF4/TC-1
(Figure 2F). K303A mutation showed consistent activity across
multiple assays; therefore, it was selected as the prototypical
separation-of-function mutant for further functional experi-
ments. Furthermore, K303A strongly attenuated recruitment of
NR4A2 to laser-induced DNA damage in vivo (Figure 2G). We
also found that mutations of the first (CEAA), the second
(C305A), or both (CC/AA) zinc-finger domains affected DNA
binding, reporter-based transcription and PAR binding (Figures
S2D–S2F) while maintaining normal nuclear localization (Fig-
ure S2C). Cysteine mutation of Zn1 (CEAA) also affected PAR
binding (Figure S2F), consistent with our prior observation
that Zn1 facilitates Zn2 folding or contributes allosterically to
Zn2 activity (Figure 1B, middle and lower panels). We conclude
that zinc-finger cysteine mutants of NR4A produce a broad
effect on DBD functionality.
Zn2 of NR4A Harbors a Distinct PAR-Binding Pocket
Localization of the PAR-binding domain to the Zn2 of NR4A sug-
gested the presence of a cleft accommodating PAR. Molecular
modeling revealed the presence of a distinct pocket in the Zn2
domain of NR4A1 (Figure 2H). Zn2s from the related NR5A class
of receptors do not possess a similar pocket (Figure 2H), consis-
tent with a divergent protein sequence (Figure 1F). Systematic
mutagenesis of amino acids forming the NR4A2 Zn2 pocket re-
vealed that most of these mutants reduced PAR-binding capac-
ity (Figure 2I) without affecting DNA binding (Figure 2K) and
maintained nuclear localization (Figure 2J). Comparison of
NR4A PAR-binding pocket to ribofuranosyladenosine (RFA)-
bound APLF (Eustermann et al., 2010) revealed that the binding
surface of NR4A1 also has a wide cleft-like fold, which could
accommodate PAR chains similar to APLF (Figure S2G). In sum-
mary, molecular modeling and empirical data identified a distinct
PAR-binding pocket in the Zn2 domain of NR4A, which could
potentially be targeted with NR4A-specific small molecules.
NR4A1 and NR4A2 Redundantly Function in the c-NHEJ
DSB Repair Pathway
Given that U2OS cells express NR4A1 and NR4A2 (Malewicz
et al., 2011), we derived NR4A1 (cA1), NR4A2 (cA2), or combined
NR4A1/2 (cA1/A2) knockout lines by CRISPR (Figures S3A–
S3C). NR4A1/2 double-knockout cells had a defect in DSB res-
olution (Figure 3A) and showed substantial radiosensitivity (Fig-
ure 3C), while single knockouts repaired DNA efficiently. cA1/
A2 cells synchronized in G1 also showed delayed DSB repair
(Figure 3B), suggesting an impairment of c-NHEJ repair
pathway. cA1/A2 cells had slightly elevated basal level of
DSBs (Figures 3A and 3B). Foci counting experiments were
corroborated with neutral COMET assays, revealing a DSB res-
olution defect in NR4A-depleted cells (Figure S3D). NHEJ is initi-
ated by Ku70/Ku80 dimer binding to free DNA ends at DSBs
(Gottlieb and Jackson, 1993). NR4A double-knockout cells
showed a substantial defect in Ku70 mobilization to DNA dam-
age sites (Figure 3D). The current model of NHEJ activation
places DNA-PKcs recruitment and autophosphorylation down-
stream of Ku loading (Meek et al., 2008). Depletion of Ku80 pro-
tein by small interfering RNA (siRNA) led to a dramatic reduction
of autophosphorylated DNA-PKcs (phDNA-PKcs) on chromatin
(Figure 3E) without affecting the levels of nuclear soluble
phDNA-PKcs. cA1/A2 cells also showed strongly decreased
levels of phosphoDNA-PKcs on chromatin at early time points
after irradiation, although the effect was less dramatic in com-
parison to Ku80-depleted cells (Figure 3F; Figure S3E). Phos-
phorylation of DNA-PKcs in the nuclear soluble compartment
was unaffected by NR4A1/2 deficiency. We conclude that
NR4A1 and NR4A2 are redundant in facilitating DNA repair via
c-NHEJ and control the levels of phDNA-PKcs on chromatin.
Autophosphorylated DNA-PKcs is critically important for activa-
tion of Artemis nuclease in c-NHEJ (Goodarzi et al., 2006). Thus,
(D) Dot blot PAR-binding assays of full-length nuclear receptors from the NR4A family.
(E) Dot blot PAR-binding assays of NR4A1 DBD, NR4A2 DBD, and LigaseIV BRCT domain.
(F) Amino acid alignment of Zn2 domains. NR4A subfamily is depicted on top (DHR38 isDrosophilaNR4A). Red frame denotes PAR-binding domain. Amino acids
in bold indicate residues conserved within the NR4A subfamily. Amino acids in red indicate residues important for PAR binding. Amino acids underlined indicate
residues important for DNA binding. NR5A family is shown in the bottom (DHR39 is the Drosophila NR5A).
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we assessed the activity of Artemis in both control and cA1/A2
cells. As reported previously (Riballo et al., 2004), siRNA-medi-
ated depletion of Artemis delayed repair of a subset of DSBs
(Figure 3G; Figure S3G). Combined NR4A1/2 and Artemis defi-
ciency resulted in an additive effect on DSB repair, demon-
strating that Artemis activity was not compromised by NR4A1/
2 deletion (Figure 3G). NR4A loss was epistatic with PARP-1
depletion (Figure 3H; Figure S3H). In contrast to NHEJ defect,
homologous recombination (HR)-associated RAD51 foci effi-
ciently formed and resolved in cA1/A2 cells (Figure 3I). Observed
DSB repair defect in cA1/A2 cells was confirmed by HR- and
NHEJ-specific reporter cassette assays (Figure S3F).
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Figure 2. Generation of NR4A2 Separation-of-Function Mutants between PAR and DNA Binding and Identification of a PAR-Binding Pocket
in NR4A Zn2
(A) Crystal structure of NR4A1 DBD with DNA oligonucleotide. Zn2 domain is shown in red and circled. Blue dots indicate zinc atoms. DNA is shown as a green
shadow.
(B) Dot blot PAR-binding assays of selected full-length NR4A2 mutants (RR/TQ, R310R312/TQ; KRRY, R310R311/TQ+K303A+Y317A; RR/AA, R310R311/AA).
(C) Electrophoretic mobility shift assays (EMSAs) of full-length NR4A2 proteins showing sequence-specific DNA binding to NBRE or mutNBRE (mutated) oligo.
(D) Reporter gene assays with NBRE- and NuRE-based luciferase reporters. RLU, relative luciferase activity. Graph represents mean RLU value (n = 3 with SD
plotted).
(E) Immunofluorescence of NR4A2 mutants after transient transfection into U2OS cells. DAPI indicates nucleus, red indicates NR4A2. Scale bar, 10 mm.
(F) Induction of endogenous C8ORF4/TC-1 gene by transient transfection of NR4A2 into U2OS cells as measured by qPCR. Fold change over LacZ control is
plotted (n = 3 with SD plotted).
(G) Laser microirradiation of transiently transfected EGFP-NR4A2 fusion proteins. Arrow shows the irradiated position in the nucleus. Scale bar, 10 mm. Graph
presents the quantification of laser microirradiation experiments (n = 3) with SD plotted above individual data points.
(H)Comparison of Zn2domains formNR4A1,NR5A1 andNR5A2 nuclear receptorswith theputativePAR-binding pocket in gray. Arrows indicatemutated residues.
(I) Dot blot PAR-binding assays with NR4A2 mutants (LA/TE, L300A301/TE). Ponceau indicates protein loading.
(J) Immunofluorescence of NR4A2 mutants after transient transfection into U2OS cells. DAPI indicates nucleus, red indicates NR4A2. Scale bar, 10 mm.
(K) Reporter gene assays with NBRE- and NuRE-based luciferase reporters. RLU, relative luciferase activity. Graph represents mean RLU value (n = 5 with SD
plotted).
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NR4A2 Zn2 Targets Poly-ADP-Ribosylated DNA-PKcs to
Facilitate DSB Repair
To address the role of PAR binding by NR4A2 in DSB repair, we
have re-expressed NR4A2 protein in cA1/A2 cells using the
retroviral expression system (Figure S4A). Endogenous NR4A2
protein is expressed in U2OS cells as full-length receptor
migrating at 66 kDa and a faster-migrating 60 kDa Tinur isoform
(Okabe et al., 1995), which lacks 62 N-terminal residues (Fig-
ure 1C; Figures S3A and S4A). The Tinur isoform showed slightly
diminished transcriptional activity in comparison to the full-
length receptor (Figure S4B) even as it efficiently translocated
to laser-induced DNA damage sites (Figure S4C). Unlike full-
length WT NR4A2, Tinur failed to reverse the DSB repair defect
in NR4A1/2 knockout cells (Figure 4A). NR4A2 K303A mutant
also failed to rescue the DSB repair defect in cA1/A2 cells (Fig-
ure 4A; Figure S4D), although it showed a residual effect on
DNA-PKcs autophosphorylation on chromatin and Ku70 recruit-
ment to DNA lesions in cA1/A2 cells (Figures 4B and 4C).
Furthermore, blocking cellular PARylation resulted in somewhat
diminished Ku70 recruitment to DSBs (Figure S4E), consistent
with earlier reports (Luijsterburg et al., 2016). In summary, full-
length NR4A2 acts in c-NHEJ in a Zn2-dependent fashion.
We hypothesized that either DNA-PKcs or Ku complex might
be the target of the NR4A2 Zn2 domain given that these proteins
(but no other core NHEJ factors) had been reported to undergo
PARylation in vivo (Martello et al., 2016) and both can interact
with NR4A receptors (Malewicz et al., 2011; Zhao et al., 2011).
We therefore purified DNA-PKcs protein and Ku70/Ku80 dimer
to homogeneity and assessed their PARylation status (Figures
4D and 4E). Consistent with very high basal level of cellular
PARylation (Figure S4F), we found PARylated DNA-PKcs and
Ku in untreated cells (Figures 4D and 4E). Only PARylation
levels of DNA-PKcs protein were elevated by ionizing radiation
(IR) treatment (Figures 4D and 4E). Next, we compared the
ability of DNA-PKcs/Ku proteins purified from IR- treated cells
(maximal PARylation) against proteins purified from cells treated
with IR and PARP inhibitor (no PARylation) to bind to the DBD of
NR4A2. Although both DNA-PKcs and Ku bound the NR4A2
DBD, only DNA-PKcs showed PAR-dependent binding (Fig-
ure 4G). We next wondered of whether the diminished Ku70
recruitment observed in cA1/A2 cells was an indirect result of a
defect in DNA-PKcs functionality. In striking similarity to cA1/
A2 cells, depletion of DNA-PKcs protein in U2OS (Figure S4G)
phenocopied the effect on Ku70 recruitment (Figure 4H). Thus,
the assembly of the NHEJ complex in human cells is cooperative
in the sense that the initial Ku binding leads to recruitment of
DNA-PKcs, which in turn stabilizes Ku at DSBs. Ku stabilization
is aided by PAR-dependent docking of NR4A2 to DNA-PKcs.
DISCUSSION
NR4As had primarily been recognized as sequence-specific
DNA-binding transcriptional regulators (Safe et al., 2016). We
and others proposed a direct role for NR4As in DNA DSB repair,
which is a DNA sequence-independent process (Malewicz and
Perlmann, 2014). In this manuscript, we present a model of
how these contrasting activities of NR4As are executed. We
find that DBD of NR4A is bi-functional and can bind DNA to regu-
late transcription (in a sequence-specific fashion) or PAR to facil-
itate DSB repair. Given that NR4A2 overexpression can accel-
erate DSB repair (Malewicz et al., 2011; Yin et al., 2017), it
appears that the DNA-PK assembly is a rate-limiting step in
this process. Thus, physiological and pathological conditions
in which the expression of NR4A is altered, such as stress re-
sponses and various cancers, might be associated with variable
NHEJ activity, with important consequences for cell physiology
and drug responses. Loss of NR4A expression in acute myeloid
leukemia (AML) is common and correlates with defective DSB
repair (Ramirez-Herrick et al., 2011). In model organism Dictyos-
telium, the Ku70 homolog bears a PAR-binding domain, which is
essential for effective c-NHEJ (Couto et al., 2011). Our data sug-
gest that in mammalian cells, NR4As perform this accessory
Figure 3. NR4A1/2 Nuclear Receptors Promote DSB Repair in G1
(A and B) DSB repair kinetics measured by 53BP1 foci resolution in asynchronized (A) or G1 synchronized (B) NR4A1/2 CRISPR cell lines at indicated time points
(m, minutes; h, hours) after 1 Gy radiation. Graph showsmean foci value per nucleus with SEM plotted (n = 3). Asterisks denote statistically significant differences
in relation to corresponding control sample (p < 0.05). Control indicates the parental U2OS cell line, cA1 indicates NR4A1 knockout cells, cA2 indicates NR4A2
knockout cells, and cA1/A2 indicates NR4A1/2 double-knockout cells. Images under the graphs show representative nuclei samples (white dashed lines) at
indicated time points, showing 53BP1 nuclear stain and DSB foci (green signal). Scale bar, 10 mm.
(C) Clonogenic survival assays. Control indicates the parental U2OS cell line, and cA1/A2 indicates NR4A1/2 double-knockout cells. Graph shows relative cell
survival at the indicated radiation dose (n = 3; SD plotted on the graph). Asterisks denote statistically significant differences in relation to the corresponding control
sample (p < 0.05).
(D) Laser microirradiation of EGFP-Ku70 fusion protein in U2OS (control) and NR4A1/2 double-knockout (cA1/A2) cells. Arrow shows the irradiated position in the
nucleus. Scale bar, 10 mm. Graph presents the quantification of laser microirradiation experiments (n = 5) with SD plotted above individual data points.
(E) Western blotting of Ku70, Ku80, and phosphor-Ser2056 DNA-PKcs (phDNA-PKcs) proteins in U2OS cells transfected with control (siControl) or Ku80-specific
(siKu80) siRNAs at indicated time points after 10 Gy irradiation. Top panel shows whole-cell extracts to reveal the extent of Ku80 depletion. Middle panel shows
the nuclear soluble fraction. Lower panel shows the chromatin fraction.
(F) Western blotting of DNA-PKcs and phosphor-Ser2056 DNA-PKcs (phDNA-PKcs) in either control cells or NR4A1/2 double-knockout cells (cA1/A2) at indi-
cated time points after 10 Gy irradiation. Top panel shows the nuclear soluble fraction. Lower panel shows the chromatin fraction.
(G) DSB levels measured as 53BP1 foci count per nucleus after 24 h post-1 Gy irradiation in control versus NR4A1/2 knockouts (cA1/A2) 72 h after transfection
with reference siRNA (siCtrl) or Artemis-specific siRNA (siArtemis) (n = 3; error bars represent SEM). Asterisks denote statistically significant differences in relation
to the control (siCtrl) sample (p < 0.05).
(H) DSB levels measured as 53BP1 foci count per nucleus after 24 h post-1 Gy irradiation in control versus NR4A1/2 knockouts (cA1/A2) 72 h after transfection
with reference siRNA (siCtrl) or PARP1-specific siRNA (siPARP1) (n = 3; error bars represent SEM). Asterisks denote statistically significant differences in relation
to the control (siCtrl) sample (p < 0.05).
(I) RAD51 foci count per nucleus at indicated times after 5 Gy irradiation in control versus NR4A1/2 knockouts (cA1/A2) (n = 3; error bars represent SD).
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function. Many cancer therapies function by inducing persistent
DNA damage (O’Connor, 2015). Inhibition of central NHEJ en-
zymes (DNA-PKcs and LigaseIV) was previously tested in the
clinic, although these efforts were unsuccessful due to the
toxicity of used compounds (Hosoya and Miyagawa, 2014).
NR4As have long been perceived as attractive targets for drug
discovery (Mohan et al., 2012). However, efforts to identify small
molecules specific to NR4As were hampered by the lack of a
suitable targeting strategy because of poor druggability of
NR4A proteins (Wang et al., 2003). Our identification of a distinct
PAR-binding pocket in Zn2 of NR4A, which operates in DSB
repair, opens a way for development of NR4A2-specific small
molecules for selective inhibition of NR4A2 PAR binding. These
in principle could be of substantial value in cancer therapy,
particularly on tumors characterized by prominent expression
of NR4As, such as breast cancer (Aesoy et al., 2015; Llopis
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Figure 4. Zn2 PAR-Binding Domain of NR4A1/2 Facilitates DSB Repair by Targeting Poly-ADP-Ribosylated DNA-PKcs Protein
(A) DSB levels measured as 53BP1 foci count after 8 or 24 h post-1 Gy irradiation in cA1/A2 after infection with recombinant retroviruses expressing indicated
proteins (n = 3; error bars represent SEM). Asterisks denote statistically significant differences in relation to the vector control sample (p < 0.05).
(B) Western blotting of DNA-PKcs and phosphor-Ser2056 DNA-PKcs (phDNA-PKcs) in cA1/A2 cells transduced with vector, WT NR4A2, or K303A NR4A2
expressing viruses at indicated time points after 10 Gy irradiation. Top panel shows the nuclear soluble fraction. Lower panel shows the chromatin fraction.
(C) Laser microirradiation of transiently transfected EGFP-Ku70 fusion protein in cA1/A2 cells stably transduced with vector, WT NR4A2, or K303A NR4A2. Arrow
shows the irradiated position in the nucleus. Scale bar, 10 mm. Graph presents the quantification of laser microirradiation experiments (n = 3) with SD plotted
above individual data points.
(D) Purified FLAG-DNA-PKcs protein from cells treated as indicated (PARPi, PARP inhibitor; IR, ionizing radiation, 20 Gy dose) were subject to western blotting
with indicated antibodies.
(E) As in (D) with purified FLAG-Ku70/Ku80 complex.
(F) Coomassie staining of indicated protein preparations (glutathione S-transferase [GST]/GST-DBD NR4A2 shows these proteins after PreScission protease
cleavage that releases DBD from GST).
(G) GST pull-downs were performed with either GST or GST-DBD NR4A2 (aa 245–360)-bound beads (baits) incubated with indicated prey proteins. Bound
material was eluted from GST beads by PreScission protease cleavage and either probed by western blotting for the presence of the DNA-PKcs/Ku complex or
stained with Ponceau S to determine the efficiency of bait cleavage.
(H) Laser microirradiation of transiently transfected EGFP-Ku70 fusion protein in U2OS cells pre-transfected for 48 h with control (siCtrl) or DNA-PKcs-specific
siRNA (siDNA-PKcs). Graph presents the quantification of laser microirradiation experiments (n = 3) with SD plotted above individual data points.
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et al., 2013). We acknowledge that substantial work is necessary
to realize this potential and to show benefit over currently used
broad PARP inhibitors such as olaparib.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse anti-tubulin Sigma-Aldrich Cat# T6074; RRID:AB_477582
Mouse anti-Ku70 Santa Cruz Cat# sc-17789; RRID:AB_628454
Mouse anti-Ku80 Santa Cruz Cat# sc-5280; RRID:AB_672929
Rabbit anti-phospho-DNA-PKcs ser2056 Abcam Cat# ab18192; RRID:AB_869495
Mouse anti-DNA-PKcs Abcam clone 18-2; RRID:AB_731982
Rabbit Anti-NR4A1 BosterBio Cat# PB9766
Rabbit Anti-NR4A2 Abcam Cat# ab41917; RRID:AB_776887
Rabbit Anti-Artemis CST Cat# #13381
Rabbit anti-H2AX Abcam Cat# ab11175; RRID:AB_297814
Mouse anti-53BP1 Millipore Cat# MAB3804; RRID:AB_2256673
Mouse anti-RanBP-1 Santa Cruz Cat# sc-374352; RRID:AB_10990126
Rabbit anti-TBP Santa Cruz Cat# sc-204; RRID:AB_632480
Rabbit anti-PAR Trevigen Cat# 4336-APC-050; RRID:AB_10643399
Mouse anti-FLAG (M2) Sigma-Aldrich Cat# F3165; RRID:AB_259529
Rabbit anti-PARP-1 Abcam Cat# ab32138; RRID:AB_777101
Rabbit anti-RAD51 Abcam Cat# ab133534; RRID:AB_2722613
Rabbit anti-Ph-(Ser/Thr) PIKK substrate CST Cat# 2851S
Goat anti-mouse HRP conjugated Pierce Cat# 32430; RRID:AB_1185566
Goat anti-rabbit HRP conjugated Pierce Cat# 32460; RRID:AB_1185567
Goat Anti-Mouse IgG FITC conjugated Jackson Immunores. Cat# 115-095-146; RRID:AB_2338599
Chemicals, Peptides, and Recombinant Proteins
Glutathione S-Sepharose 4B GE Healthcare Cat. 17075601
M2 agarose Sigma-Aldrich Cat. A2220; RRID:AB_10063035
32P-labeled NAD Hartmann Analytic Cat. ARP0141
Critical Commercial Assays
Fast SYBR Green Master Mix ThermoFisher Cat. 4385612
Subcellular fractionation kit ThermoFisher Cat. 78840
Pierce Firefly Luciferase Glow Assay Kit ThermoFisher Cat. 16177
Galacto-Light Plus b-Galactosidase Assay ThermoFisher Cat. T1007
Experimental Models: Cell Lines
U2OS ATCC Cat# HTB-96, RRID:CVCL_0042
293H Invitrogen N/A
293H stably expressing FLAG-DNA-PKcs Craxton et al., 2015 N/A
Oligonucleotides
GAPDH F GGAGTCAACGGATTTGGTCGTA This study N/A
GAPDH R GAATTTGCCATGGGTGGAAT This study N/A
C8ORF4/TC-1 F AAGCCACCAAGCCATCATCA This study N/A
C8ORF4/TC-1 R TCTTGGCTCTCTCCTCTGCT This study N/A
Recombinant DNA
pGEX-6P-1 GE Healthcare Cat. 28-9546-48
pCMX mammalian expression vector Malewicz et al., 2011 N/A
pEGFP-N1 Clontech N/A
pBabe-puro Addgene Cat. 1764
pDRGFP Addgene Cat. 26475
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and request for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Michal
Malewicz (mzm23@mrc-tox.cam.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
U2OS human osteosarcoma cell line was obtained from ATCC and cultured in DMEM medium (high glucose) supplemented with
10% FCS. 293H cells were purchased from Invitrogen and cultured in DMEM medium (high glucose plus pyruvate) supplemented
with 10% FCS. For G1 cell cycle synchronization standard double thymidine block protocol had been used.
METHOD DETAILS
Western blotting
Cell extracts (WCE/whole cell extracts or nuclear extracts) were mixed with 4x Laemmli sample buffer (Bio-Rad; cat. 1610747)
and boiled for 5min. Samples were then resolved on pre-cast TGX gradient 4%–15% gels (Bio-Rad). Gels were transferred to nitro-
cellulosemembranes via Trans-Blot Turbo system (Bio-Rad) according tomanufacturer’s instructions. After transfer, themembranes
were blocked in BLOTTO TBS-T blocking solutions for at least 30min at room temperature. Primary antibodies were applied in 5%
BSA TBS-T solution for overnight 4C incubations. Secondary antibodies (HRP-coupled stabilized IgG from Pierce) were applied in
TBS-T solution for 1hr at room temperature. Western blots were subsequently developed with Clarity HRP substrate (Bio-Rad) and
exposed to Hyperfilm ECL films (GE Healthcare).
Plasmids/Cloning
GST fusion vectors were constructed by inserting PCR amplified full length NR4A1, NR4A2, NR4A3, DHR38, NTD/DBD/LBD/Zn1/
Zn2/CTE of NR4A2 andDBDof NR4A1 coding fragments or hLigaseIV BRCT domain (aa 600-911) into pGEX-6P-1 vector (GEHealth-
care) using the Quick ligation kit (NEB Inc). The PCR amplified inserts were prepared using the Q5 High–Fidelity DNA polymerase
(NEB Inc). The inserts were cloned into the pGEX-6P-1 vector at the BamHI (or BglII) and XhoI cloning sites. Cloning was verified
by diagnostic digestion using restriction enzymes followed by DNA sequencing (PNACL - University of Leicester, Leicester, UK).
pCMXmammalian expression vectors encoding full-length NR4A1, NR4A2, NR4A3 andDHR38were previously described (Malewicz
et al., 2011). For the generation of mCherry-NR4A2 fusions PCR amplified full-lengthmouse NR4A2 were subcloned in mCherry-LacI
plasmid (gift from Dr Tom Misteli, NIH, USA). For generation of EGFP-NR4A2 fusions PCR amplified full-length mouse NR4A2 was
cloned in-frame into pEGFP-N1 plasmid (Clontech).
Generation of recombinant retroviruses
VSV-pseudotyped retroviruses were generated with Clontech Pantropic Retroviral Expression System (Cat. No. 631512) based on
pBabe-puro (Addgene) vector and according to manufacturer’s instructions. Recombinant retroviruses carrying empty vector, F-L
NR4A2 WT, Tinur or F-L NR4A2 K303 cDNAs were generated according to manufacturer’s instructions. In brief GP2-293 packaging
cell line (Clontech/TaKaRa) was transiently transfectedwith amixture of plasmids containing pBabe-puro vector and coat expression
plasmid (VSV). After 72hr of incubation conditioned medium was harvested, filtered through 0,45 mm syringe top filter and applied to
target cells in the presence of polybrene (SantaCruz). After 24hr of incubation stably transduced cells were selected out by puromycin
selection (2 mg/ml; Invitrogen).
SiRNA-mediated mRNA knockdown
Control (reference), Ku80-, Artemis-, PARP1-, DNA-PKcs-specific siRNA were purchased from SantaCruz Biotechnology and trans-
fected to U2OS by Lipofectamine RNAiMAX (Life Technologies) at 50nmol concentration. Cells were analyzed at 48-72hr post
transfection.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
pimEJ5GFP Addgene Cat. 44026
pGL3-Basic Promega N/A
Software and Algorithms
Prism 6 for MacOS X GraphPad Software N/A
PyMOL Molecular Graphic system, version 1.6.0.0 Schro¨dinger, LLC N/A
e2 Cell Reports 26, 2028–2036.e1–e6, February 19, 2019
Site directed mutagenesis
The site directed mutagenesis was performed using PfuUltra High Fidelity DNA polymerase (Agilent Technologies). The reaction
mixture contained 0.2mM dNTPs, 50ng template plasmid, 2.5U Pfu DNA polymerase and 125ng of each primer. PCR amplification
reaction required 18 cycles of step 1: 98C for 30sec, step 2: 95C for 30sec, step 3: 55C for 1min, step 4: 68C for 5mins. PCR
product was subjected to 2 cycles of incubation with 20U DpnI (NEB Inc) enzyme at 37C for 1h, then transformed into NEB 5-alpha
E.coli strain (NEB Inc). Recovered plasmids were sequenced via in-house sequencing facility (PNACL - University of Leicester,
Leicester, UK) to identify desired mutations.
Recombinant protein expression and purification
1-10ng/ml of pGEX-6P-1 plasmid containing desired cDNA for expression (GE Healthcare) was transformed in 10 mL aliquot of
Rosetta 2 competent cells (Novagen). Transformed cells were spread onto ampicillin agar plate and incubated overnight at 37C.
Individual colony was picked into a 100mL LB starter culture containing 100 mg/mL ampicillin and 34 mg/mL chloramphenicol and
incubated overnight at 37C. The starter culture was further expanded into 500mL culture containing ampicillin and chloramphenicol
and incubated for 6h at 37C. The culture was then induced with 0.1mM IPTG and allowed to express the recombinant protein over-
night at 18C. Following induction, the culture was supplemented with 50 mMZnCl2. Cells were harvested by centrifugation at 6000 g
for 15mins at 4C. The cells were suspended in 20mL GST lysis buffer (50mM Tris pH 7.5, 150mM NaCl, 1% Triton X-100, 0.1%
b-mercaptoethanol, 0.4mM PMSF, 1X EDTA free Complete Protease Inhibitor cocktail (Roche) and 1mM benzamidine) and lysed
by sonication. The lysate was then centrifuged at 20000 g for 30mins at 4C. The cleared cell lysate supernatant was incubated
with 200 mL pre-washed gluthathione Sepharose 4B (GE Healthcare) for 1h at room temperature. The protein bound beads were
washed thoroughly with GST-wash buffer (50mM Tris pH 7.5, 500mM NaCl, 1% Triton X-100, 0.1% b-mercaptoethanol, 0.4mM
PMSF, 0.5X EDTA free Complete Protease Inhibitor cocktail (Roche) and 1mM benzamidine). The beads were equilibrated with
cleavage buffer (50mM Tris pH 7.0, 150mM NaCl and 1mM DTT). To obtain GST-tag cleaved recombinant proteins the beads
were incubated with 100 mL cleavage buffer supplemented with 15U PreScission Protease (GE Healthcare) overnight at 4C. Protein
concentration was measured using NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific). For experiments shown in
Figure 2B NR4A2 full-length protein preparations were further purified by gel filtration on A¨ktamicro system (GE Healthcare) using
Superdex 200 Increase 3.2/300 gel filtration column according tomanufacturer’s protocol. The proteins were further electrophoresed
on precast 4%–15% Mini-PROTEAN TGX gels (Bio-Rad) and stained with quick Coomassie stain (InstantBlue; manufactured by
Expedeon) to assess quality.
Neutral COMET assays
To induce double strand DNA breaks (DSBs) cells were treated with 100 mg/ml of zeocin (bleomycin derivative; Invitrogen) for 30min.
Thereafter cells were either washed with medium to remove the zeocin and allow DNA repair to continue for 90min or harvested
directly for COMETs. 100x103 cells were mixed with 100 mL of LMP agarose in PBS (In-Cert, LONZA) and spread on a frosted micro-
scope slide (precoated with standard 1% agarose; LONZA) and covered with 64mm coverslip. Agarose was allowed to solidify for
15min in the fridge. Subsequently coverslip was removed and the microspore slide with cells embedded in agarose was incubated in
neutral lysis solution (2% sarkosyl, 0.5M EDTA, 0.5mg/ml proteinase K, pH 8.0) overnight in the fridge followed by 1hr at 37C. Slides
were then submerged in 1xTBE buffer for 30min in the cold room and subsequently electrophoresed at 15V for 15mins in 1xTBE
buffer. Slides were recovered from the electrophoresis chamber and placed in DNA precipitation solution (1M ammonium acetate
in 99% ethanol) for 30min at room temperature. Slides were then washed with 70% ethanol for 10min at room temperature, air-
dried and stained with SYBRGOLD stain. Subsequently slides were mounted with Vectashield HardSet mounting medium (Vector
Labs). COMETs images were acquired on a fluorescentmicroscope and quantified as percentage (%) of DNA in tail with CometScore
(TriTec Corp., USA). At least 30 COMETs were scored per sample.
Purification of FLAG-DNA-PKcs and FLAG-Ku70/Ku80 proteins from mammalian cells
FLAG-tagged proteins were purified from suspension grown 293 cells (for FLAG-DNA-PKcs a stable clonewas used; for FLAG-Ku70/
Ku80 complex cells were transiently transfected with pCMX-FLAG-Ku70 and pCMX-FLAG-Ku80 expression vectors). Cells were
washed twice in ice-cold PBS-MC (PBS, 1 mM MgCl2, 1 mM CaCl2) and gently resuspended in 4.5 ml ice-cold Hypotonic Buffer
(10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA supplemented with Complete protease inhibitors (Roche
Diagnostics), 10 mM NaF, 1 mM Na3VO4, 10 mM MG132, 1 mM DTT, 1 mM PMSF). After incubation for 15 min, Igepal CA630
was added to 0.05% final concentration and cells were vortexed for 10 s and centrifuged at 2300 3 g for 5 min. Crude nuclei
werewashedwith 1 ml Hypotonic Buffer and re-centrifuged as above. Pelletsmixed by end-to-end rotation with 15 ml high salt buffer
(20 mMHEPES, pH 7.9, 500 mMNaCl, 0.5 mMMgCl2, 20% glycerol) supplemented as described above for 30 min on ice. Following
centrifugation at 15000 3 g for 30 min, nuclear extracts were incubated with M2 beads (SigmaAldrich) for 1-2hr on ice, beads were
subsequently washed 3x10ml of 1M NaCl containing buffer to remove any associated proteins. Pure proteins eluted with elution
buffer containing 0.2 mg/ml 3X FLAG peptide (SigmaAldrich).
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GST pull downs
GST control protein (expressed from empty pGEX-6P plasmid) or GST-DBD NR4A2 (aa245-360 as indicated on Figure 1C) were ex-
pressed in bacteria according to standard GST purification protocol (see above) and bound to GST beads. Equimolar amounts of
pure FLAG-DNA-PKcs (derived from a cell line stably expressing FLAG-DNA-PKcs protein) or FLAG-Ku70/Ku80 (derived from cells
transiently transfected with pCMX-FLAG-Ku70/pCMX-FLAG-Ku80 plasmids) proteins purified from DMSO or PARPi (pan-PARP in-
hibitor - olaparib; 10 mM; pre-treatment 3hr prior to IR) pre-treated cells plus/minus 20Gy ionizing radiation (IR) were incubated with
GST beads for 1hr on ice in a buffer containing 50mM Tris pH 7.5, 150mMNaCl, 0.5% Triton X-100 and 1mM DTT. Thereafter beads
were washed with 3x1ml of binding buffer containing 300mMNaCl. Beads were equilibrated in PreScission protease cleavage buffer
and then digested with 10U of PreScission protease in 75ul buffer volume for 4hrs. Eluates were run on SDS-PAGE and bound DNA-
PKcs or Ku70/Ku80 were detected by western blotting. The efficiency of bait cleavage was confirmed by Ponceau S (Sigma) staining
of the membrane prior to blocking.
PAR dot-blot binding assays
1 mg and 2 mg protein were spotted on nitrocellulose membrane for PAR binding and Ponceau S staining respectively. Protein dilu-
tions were prepared in 200 mL TBS buffer (pH 7.5). Proteins were spotted using the Bio-Dot microfiltration Apparatus (Bio-Rad). Nitro-
cellulose membrane spotted with protein were incubated with Ponceau S stain (Sigma) for 5 mins followed by several quick washes
with ultra-pure water to remove excess stain. For radioactive in vitroPAR binding assays, BLOTTO-blockedmembranes with spotted
proteins were incubated with radioactively-labeled PAR for 1hr at room temperature in TBS-T. Membranes were subsequently
washed with TBS-T and TBS-T containing 1M NaCl. Washed and dried membranes were exposed to Hyperfilm MP (GE Heathcare).
Radioactive PARwas synthesized in 50 mL reactions containing 10 mL of 5x PAR synthesis buffer (1x buffer = 25mMTris-Cl ph.8, 0.1M
NaCl, 10mM MgCl2 and 0.5mM DTT), 2 mL (20U) of recombinant human PARP-1 enzyme (Trevigen or SigmaAldrich), 2.5 mg calf
thymus DNA (Invitrogen), 1 mL of 50mM NAD and 5 mL of 32P-labeled NAD (800 Ci/mmol; Hartmann Analytic) for 30min at 25C.
PAR chains were detached form PARP-1 by sequential addition to these reactions of DNase and proteinase K (NEB) followed by
heat inactivation.
EMSA/Gel shift assay
The DNA oligos (NBRE: 50-GATCCTCGTGCGAAAAGGTCAAGCGCTA-30 and 50-GAGCACGCTTTTCCAGTTCGCGATCTAG-30;
mutNBRE: 50-GATCCTCGTGCGAAAAGGTCAAGCGCTA-30 and 50-GAGCACGCTTTTCCAGTTCGCGATCTAG-30) were annealed
by combining two single strand oligos in TE buffer pH 7.5 and 50mM NaCl, heating at 80C for 15mins and then gradually cooling
to room temperature. 2pmol annealed oligo was radioactively labeled using 10 mCi/ml a32P-dCTP (PerkinElmer), 0.1mM dNTPs
(without dCTP), 5U Klenow fragment (NEB Inc) and 1XNEB 2 buffer incubated for 20mins at room temperature. The probewas further
subjected to illustra ProbeQuant G-50 micro column (GE Healthcare) purificatioin to remove excess of unincorporated a32P-dCTP.
Gel shift reaction mixture contained 1 mg protein, binding buffer (10mM Tris pH 8, 50mM NaCl, 1mM EDTA, 5% glycerol and 5mM
DTT), 20ng/ml competitor dIdC (SigmaAldrich), 1.25mg/ml BSA and radioactive labeled oligos (NBRE or mutNBRE). The reaction was
incubated for 20mins at room temperature. Loading dye (bromophenol blue 0.25%, xylene cyanol 0.2% and Ficoll 15%) was then
added to the reaction mixture. The reaction mixture was loaded on 5% polyacrylamide gel using 0.25X TBE as running buffer. Prior
to loading of the samples, the gel was pre-run for 15-30mins at 150V. The gel was then dried using Bio-Rad gel dryer system at 80C
and subjected to autoradiography.
Reporter gene assays
NuRE or NBRE based reporter gene was constructed by cloning four copies of NuRE (Philips et al., 1997) or NBRE response element
in front of TK minimal promoter in pGL3 basic vector driving the expression of firefly reporter gene (Promega). Reporter gene assays
were performed by co-transfection the reporter plasmid, NR4A2 expression plasmid and LacZ expression vector into U2OS cells in
24 well format in triplicates. After 24hr of incubation cells were lysed in 150 mL of passive lysis buffer (Promega). Luciferase assays
were performed with commercial kit (cat. 16177; ThermoFisher Scientific) according to manufacturer’s manual and normalized to
galactosidase activity (cat. T1007; Galacto-Light Plus b-Galactosidase Reporter Gene Assay System; ThermoFisher Scientific).
Luciferase and galactosidase activity was measured in 96 well white plates read by multi-plate reader VictorX4 (Perkin Elmer).
CRISPR-Cas9-mediated deletion of NR4A1 and NR4A2
U2OS cells were transfected with a CMV promoter-driven Cas9-Puro expression vector and predesigned guide RNAs (gRNA) (Dhar-
macon) for each targeted gene using Lipofectamine 2000. After 24 hr at 37C, puromycin (4 mg/ml) was added for an additional 24 hr
to select for Cas9-expressing cells, and subsequently replacedwith DMEM in the absence of puromycin for a further 48 hr. Thereafter
cells were plated at a density of 500 cells per 10 cm dish or plated in 96-well plates at a density of 12.5 cells/ml. After 10-12 days,
individual colonies were transferred to 12-well plates using trypsin/EDTA-soaked cloning discs, expanded and subsequently
analyzed by immunoblotting for expression of NR4A1 and NR4A2. Identification of CRISPR-Cas9-mediated mutations (indels)
near gRNA target sequences (Figure S3C) was performed by amplification of 0.4-1kb genomic DNA regions spanning gRNA target
sequences (near PAM/cleavage sites) using Q5 high fidelity DNA polymerase. PCR products were ligated into pJET1.2 and DNA
sequencing performed on plasmids recovered from bacteria for each independent clonal knockout cell line.
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Molecular modeling
Figures 2A and 2H were prepared using PyMOL Molecular Graphic system, version 1.6.0.0 (Schro¨dinger, LLC). Crystal structure of
NR4A1/NGFI-B DBD with DNA (PDB: 1CIT; (Meinke and Sigler, 1999)) was used to create Figure 2A. MetaPocket 2.0 online server
(Ref: https://academic.oup.com/bioinformatics/article/27/15/2083/402380 and https://www.liebertpub.com/doi/abs/10.1089/omi.
2009.0045) was used to predict ligand binding pocket on protein surface shown in Figure 2H. Crystal structure of DBDs from
NR4A1/NGF1-B and NR5A2 (PDB: 1CIT and PDB: 2A66 respectively) and solution structure of NR5A1 (PDB: 2FF0) were used for
ligand pocket prediction (Figure 2H). Crystal structure of NR4A1/NGFI-B DBD with DNA (PDB: ICIT; (Meinke and Sigler, 1999) and
solution structure of first PBZ domain of APLF in complex with RFA were used to create Figure S2G (PDB: 2KQD; (Eustermann
et al., 2010)). The online server MetaPocket 2.0 (Huang, 2009) was used to predict the ligand binding pocket for NR4A1 structure.
MetaPocket is a consensus based method that combines results from four predictor methods: LIGSITEcs, PASS, Q-SiteFinder,
and SURFNET to provide an improved prediction success rate. In short, the server verifies result from each predictor site, calculates
a z-score for each prediction, obtains tops 3 pocket sites from each predictor and clusters them according to spatial similarity. There-
after the algorithm ranks the clusters based on their z-score and finally calculates a mass center for each cluster further providing the
user with an output information of prediction pocket site as single point or clusters. MetaPocket 2.0 as an online server works on the
user-supplied structure information of protein of interest to find potential ligand binding pockets. For this we initially used two ap-
proaches; (i) we used the NR4A1/NGFI-B DBD with DNA (PDB: 1CIT) directly and (ii) we removed the DNA structure from the
1CIT structure and used this as a starting structure to predict pocket. Based on the calculations used by the server, using the
PBD structure directly with DNA only predicted cluster pockets within the DNA. Therefore, in the second approach, when DNAmole-
cule was removed from structure, the top pocket predictions were – (i) region of protein that we know from NR4A1/NGFI-B DBD
structure to directly interact with DNA and (ii) a more globular shaped pocket that was predicted away from DNA binding site in
the Zn2 domain of NR4A2, which we show in Figure 2H. Using the same web server, we also performed a ligand pocket prediction
for NR5A receptor (PDB: 2A66) and NR5A1 receptor (PDB: 2FF0) proteins without DNA molecule.
Immunofluorescence
Cells were transfected with pCMX-NR4A2 encoding plasmids and at 24hr post-transfection were seeded on 8-well cluster chamber
slides at 0.05x106/well. After overnight incubation cells were fixed with 4% PFA at RT for 10min. Cells were washed with PBS and
then incubated in blocking/permeabilisation solution (5% normal goat serum, PBS and 0.03% NP-40) at 4C for 1hr. Primary anti-
bodies were applied in blocking solution and slides were incubated overnight at 4C. After subsequent PBS wash, secondary anti-
bodies (Jackson Immunoresearch) were applied in blocking solution and slides were incubated 1hr at RT. Images were acquired on
Zeiss LSM 510 confocal microscope.
Transfections
Cells were transiently transfected according to manufacturer’s instructions. For plasmid and siRNA/plasmid the Lipofectamine 2000
(U2OS) or LTX/Plus (293HEK) was used. For siRNA transfections Lipofectamine RNAiMAX was used.
Cell fractionation
Subcellular fractionation was performed with commercial kit (Product 78840, ThermoFisher Scientific) according to manufacturer’s
manual. Each time point corresponds to subconfluent 6cm dish of ca 1-2 3 106 cells.
Measuring HR and NHEJ efficiency with reporter cassettes
HR (pDRGFP plasmid; Addgene; (Pierce et al., 1999)) and NHEJ (pimEJ5GFP; Addgene; (Bennardo et al., 2008)) reporter plasmids
were stably integrated into U2OS (Parental) or cA1/A2 cells by transient transfection followed by selection of stable cell lines with
puromycin. For the measurement of the HR and NHEJ efficiency cells were transiently transfected in triplicate with I-SceI expression
vector (gift from dr Benjamin Chen, UTSouthwestern). After 24hr of incubation GFP positive cells were quantified by FACS. Trans-
fection efficiency was monitored by RFP co-expression. Efficiency of HR and NHEJ in cA1/A2 cells was calculated as percentage
of efficiency observed in Parental cells that was set to 100%.
Laser Micro-irradiation and Live Cell Imaging
U2OS cell were transiently transfected with EGFP-Ku70 or EGFP-N1-NR4A2 expression plasmids with the use of Lipofectamine
2000. After 48 hr cells were presensitized with Hoechst 33342 (10 mM) immediately prior to live cell imaging. Live cell time lapse im-
aging combining laser micro-irradiation with confocal microscopy was performed by capturing images on a Marianas-SDC system
from Intelligent Imaging Innovations (3i). This systemuses a YokogawaCSU-Wwith 150mW488nmexcitation andHamamatsu Flash
4.0 v2+ camera. DNA damagewas introduced using the 3i ‘Ablate’ UV 355 nmpulsed laser system (70 mJ per pulse at 200Hz) which is
focused to a diffraction limited spot at the sample plane and steered along a user-defined line by the 3i ‘VectorM’ MEMS mirror
scanner and Slidebook software. Relative intensity at laser-damaged sites was calculated as the mean value of the intensity of
each damage site at each time point after background subtraction. At least 10 cells were scored per sample and per experiment.
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Images presented in Figure 1A were generated according to (Mehrotra et al., 2011). In some experiments DMSO (Sigma-Aldrich) or
10 mmPARP inhibitor (PARPi; olaparib; purchased from SantaCruz biotechnology) was used to pre-treat cells 15-30min prior to laser
irradiation.
DSB foci counting
Cells were fixed in PFA and stained with anti-53BP1 antibodies and DAPI (for RAD51 foci detection cells were fixed with methanol).
Images of nuclei were acquiredwith highmagnification to visualize individual 53BP1 nuclear foci. Individual foci were counted and the
data was presented as mean foci per nucleus value. At least 30 cells were counted per sample per experiment.
Clonogenic survival assays
U2OS (Parental) or cA1/A2 cells were plated in triplicate at densities of 1000–30000 cells per 10 cm dish and exposed to X-Rays
(0–4 Gy) and grown for 10–14 days to form colonies. Colonies were fixed in 75% methanol/25% acetic acid, prior to staining with
PBS/0.05% (w/v) crystal violet and counting. The survival fraction was determined from the plating efficiency of the specific IR
dose relative to the plating efficiency of non-irradiated controls.
Identification of C8ORF4/TC-1gene as NR4A2 target
U2OS cells were transiently transfected with pCXM-LacZ (mock control), pCMX-NR4A2WT, pCMX-NR4A2 K303A or pCMX-NR4A2
R319A expression plasmids. After 16hr cells were harvested and total RNA was extracted (QIAGEN RNAeasy kit) and hybridized to
60K whole human genome microarrays (Agilent Technologies, Berkshire, UK), following the manufacturer’s protocol. RNA was first
checked for quality using a 2100 Bioanalyser (Agilent). RNAwith a RIN score of > 9was used for microarray analysis. 200 ng RNAwas
Cy-3 labeled using Agilent Low Input Quick Amp 1-color Labeling Kit (Agilent). The level of dye incorporation was measured using a
Nanodrop ND1000 spectrophotometer (LabTech, Sussex, UK). 600 ng Cy-3 labeled sample was fragmented using fragmentation
buffer from the Agilent Gene Expression Hybridization Kit (Agilent) for 30 min at 60C. Fragmented samples were mixed 1:1 with
Hybridization Buffer (v/v) and hybridized to a 60K high-density oligonucleotide microarray overnight. Microarrays were loaded as
per the manufacturer’s instructions and hybridization was performed at 65C, in an Agilent Hybridization Oven with rotation set to
10 RPM for 17 h. Following hybridization, the microarray slides were washed in Gene Expression wash buffers 1 and 2 (Agilent)
and immediately scanned using a DNA Microarray Scanner (Model G2505C, Agilent Technologies) at 3 mm resolution. Scanned
images were uploaded into Agilent’s Feature Extraction software (v. 10.7.3.1). Within array normalization, background subtraction
and flagging of outliers due to saturation or non-uniformity was performed. Processed signal data for each probe was extracted
for further analysis. Extracted data was analyzed using GeneSpring GX 12.6.1. Data was normalized to the 75th percentile and
then subjected to a moderated one-way ANOVA test. Genes were declared as differentially regulated if they showed a fold change
ofR 2 with corrected p value% 0.05 after Benjamini Hochberg based False Discovery Rate correction. This led to identification of
C8ORF4/TC-1gene as NR4A2 responsive target (Table S1). C8ORF4/TC-1upregulation after transfection of NR4A2 was verified by
qPCR as follows: 16hrs after transfection RNA was extracted from cells using RNeasy kit (QIAGEN). Reverse transcription reaction
was conducted with superscript II (ThermoFischer Scientific) using 1 mg of total RNA. qPCR was conducted using FAST SYBR green
qPCRpremix (Applied Biosystems, ThermoFisher Scientific) and plates were analyzed on Quantstudio 6 flex (Applied Biosystems).
QPCR results were quantified using delta delta ct method with GAPDH serving as reference.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed with GraphPad Prism software (v. 6). Statistical significance was assessed with paired two-tailed
t test. Results were considered statistically significant when p value was lower than 0.05; SD represents standard deviation; SEM
denotes standard error of the mean; n value represents the number of biological replicates.
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